Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last kr329.90 DKK
Change Today -8.30 / -2.45%
Volume 893.3K
NZYMB On Other Exchanges
Symbol
Exchange
OTC US
OTC US
Copenhagen
Frankfurt
As of 11:04 AM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - NOVOZYMES A/S-B SHARES (NZYMB)

Novozymes A/S to Report Fiscal Year 2015 on Jan 19, 2016
CapIQ 01/19/2016 5:00 AM ET
Novozymes A/S to Report Nine Months, 2015 on Oct 22, 2015
CapIQ 01/19/2016 5:00 AM ET
Novozymes A/S to Report First Half, 2015 on Aug 06, 2015
CapIQ 01/19/2016 5:00 AM ET

2013 revenues at Novozymes A/S totaled kr11.7B DKK, while annual earnings equaled kr6.93 per share.

Quarterly Earnings & Estimates - NOVOZYMES A/S-B SHARES (NZYMB)

Actuals vs. Estimates for NOVOZYMES A/S-B SHARES NZYMB

Novozymes A/S's Quarterly Earnings

Novozymes A/S reported 2nd quarter 2014 earnings of kr1.87 per share on 08/16/2014.

Annual Earnings & Estimates - NOVOZYMES A/S-B SHARES (NZYMB)

Actuals vs. Estimates for NOVOZYMES A/S-B SHARES NZYMB

Novozymes A/S's Annual Earnings

Novozymes A/S reported annual 2013 earnings of kr6.93 per share on 01/23/2014.

Quarterly Revenues - NOVOZYMES A/S-B SHARES (NZYMB)

Actuals vs. Estimates for NOVOZYMES A/S-B SHARES NZYMB

Novozymes A/S's Quarterly Revenues

Novozymes A/S had 2nd quarter 2014 revenues of kr3.1B DKK. This missed the kr3.2B DKK consensus estimate of the 6 analysts following the company. This was 1.2% above the prior year's 2nd quarter results.

Annual Revenues - NOVOZYMES A/S-B SHARES (NZYMB)

Actuals vs. Estimates for NOVOZYMES A/S-B SHARES NZYMB

Novozymes A/S's Annual Revenues

Novozymes A/S had revenues for the full year 2013 of kr11.7B DKK. This was 4.6% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NZYMB:DC kr329.90 DKK -8.30

NZYMB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Chr Hansen Holding A/S kr341.10 DKK -4.20
Ebro Foods SA €18.16 EUR -0.23
EMS-Chemie Holding AG SFr.388.75 CHF -10.00
Kerry Group PLC €68.25 EUR -0.99
Sensient Technologies Corp $66.47 USD -1.77
View Industry Companies
 

Industry Analysis

NZYMB

Industry Average

Valuation NZYMB Industry Range
Price/Earnings 36.7x
Price/Sales 7.3x
Price/Book 8.0x
Price/Cash Flow 30.2x
TEV/Sales 5.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVOZYMES A/S-B SHARES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.